Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
Adaptimmune Therapeutics Revenue
Adaptimmune Therapeutics reported an annual revenue of $178.03M, reflecting a 195.34% growth. For the quarter ending March 31, 2025, Adaptimmune Therapeutics generated $7.29M in revenue.
Revenue (ttm)
178.03M
Revenue Growth
195.34%
Price / Sales Ratio
0.76
Revenue / Employee
351.84K
Employees
506
Market Cap
72.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 178.03M | +195.34% |
| Dec 31, 2023 | 60.28M | +122.05% |
| Dec 31, 2022 | 27.15M | +341.50% |
| Dec 31, 2021 | 6.15M | +55.36% |
| Dec 31, 2020 | 3.96M | n/a |